2 months ago
KROS
AnalystsJulian HarrisonJulian Harrison's Stock Forecasts
AnalystsJulian Harrison
Sectors:
Industries:
Analyst Ranking
Top 14%
#582 out of 4174 analysts
Average Return
+32.18%
Win Rate
67%8 out of 12
Risk vs Reward
Poor
Good
Julian Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Prometheus Biosciences IncRXDX | +150.15% | $43.05 | $107.69 | 2022-02-10 - 2023-02-06 | Strong Buy |
Aerovate Therapeutics IncAVTE | +116.12% | $10.30 | $22.26 | 2022-02-10 - 2022-08-16 | Strong Buy |
Prometheus Biosciences IncRXDX | +79.48% | $60.00 | $107.69 | 2022-10-02 - 2023-02-06 | Strong Buy |
Keros Therapeutics IncKROS | +76.82% | $31.79 | $56.21 | 2022-07-25 - 2023-02-06 | Strong Buy |
Aerovate Therapeutics IncAVTE | +38.66% | $18.03 | $25.00 | 2022-12-05 - 2023-02-06 | Strong Buy |
Julian Harrison Analyst Color
Get additional color on Julian Harrison's coverage of popular stocks
2 months ago
RXDX
4 months ago
RXDX
Julian Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Keros Therapeutics IncKROS | 2 | Strong Buy | $105.00 | +86.80% | Maintains | 2 months ago |
Prometheus Biosciences IncRXDX | 3 | Strong Buy | $181.00 | +68.08% | Maintains | 2 months ago |
Aerovate Therapeutics IncAVTE | 3 | Strong Buy | $27.00 | +8.00% | Upgrades | 2 months ago |
Outlook Therapeutics IncOTLK | 1 | Strong Buy | $7.00 | +455.56% | Initiates Coverage On | 3 months ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $32.00 | +133.07% | Initiates Coverage On | 4 months ago |
Liquidia CorpLQDA | 1 | Strong Buy | $17.00 | +146.38% | Maintains | 7 months ago |
Biora Therapeutics IncBIOR | 1 | Strong Buy | $4.00 | -1.48% | Assumes | 9 months ago |
United Therapeutics CorpUTHR | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Morphic Holding IncMORF | 1 | Strong Buy | $64.00 | +81.41% | Initiates Coverage On | a year ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.